USP1 and neoplasm: Taken together, these findings indicate that USP1 inhibitor markedly enhances the innate immune response within tumor tissues following RT and suggest that targeting USP1 may substantially influence the immunophenotypic remodeling of the tumor microenvironment post‐RT.